NCT04965350View on ClinicalTrials.gov

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

PHASE3CompletedINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

April 20, 2021

Primary Completion Date

April 27, 2022

Study Completion Date

May 16, 2022

Conditions
HPV Infection
Interventions
BIOLOGICAL

Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)

sterile solution for intramuscular injection

Trial Locations (1)

Unknown

Mianyang Center for Disease Control and Prevention, Mianyang

All Listed Sponsors
collaborator

Yuxi Zerun Biotechnology Co., Ltd.

UNKNOWN

lead

Shanghai Zerun Biotechnology Co.,Ltd

INDUSTRY